”Personally, I was hoping the biochip progress would underpin the 12cq chip development. The AGM presentation barely mentioned the biochip.
I feel AXE is in a near term world of hurt if the AGM Presentation is taken literally.”
The biochip and the 12CQ chip are progressing and progressing exceptionally well by all accounts. But time may be on the buyers side. Unless there is interest from major industry participants in the near term, I feel AXE’s share price trend will continue and funds will be diverted to stocks that are trending better.
I feel most of the sellers are small holders and much of it is being mopped up by secure hands. I could be wrong.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)